» Articles » PMID: 35222392

CD3CD4CD8 (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer

Overview
Journal Front Immunol
Date 2022 Feb 28
PMID 35222392
Authors
Affiliations
Soon will be listed here.
Abstract

The crucial role of CD4 and CD8 T cells in shaping and controlling immune responses during immune disease and cancer development has been well established and used to achieve marked clinical benefits. CD3CD4CD8 double-negative (DN) T cells, although constituting a rare subset of peripheral T cells, are gaining interest for their roles in inflammation, immune disease and cancer. Herein, we comprehensively review the origin, distribution and functions of this unique T cell subgroup. First, we focused on characterizing multifunctional DN T cells in various immune responses. DN regulatory T cells have the capacity to prevent graft-versus-host disease and have therapeutic value for autoimmune disease. T helper-like DN T cells protect against or promote inflammation and virus infection depending on the specific settings and promote certain autoimmune disease. Notably, we clarified the role of DN tumor-infiltrating lymphocytes and outlined the potential for malignant proliferation of DN T cells. Finally, we reviewed the recent advances in the applications of DN T cell-based therapy for cancer. In conclusion, a better understanding of the heterogeneity and functions of DN T cells may help to develop DN T cells as a potential therapeutic tool for inflammation, immune disorders and cancer.

Citing Articles

Thyroid Cancer-The Tumor Immune Microenvironment (TIME) over Time and Space.

Jaume J Cancers (Basel). 2025; 17(5).

PMID: 40075642 PMC: 11899416. DOI: 10.3390/cancers17050794.


Modulation of double-negative T cells by Huang-Lian-Jie-Du Decoction attenuates neuroinflammation in ischemic stroke: insights from single-cell transcriptomics.

Wang K, Sun Z, Shao Q, Wang Z, Zhang H, Li Y Front Immunol. 2025; 16:1537277.

PMID: 40018035 PMC: 11865039. DOI: 10.3389/fimmu.2025.1537277.


The effects of immune cell phenotypes and plasma metabolomes on diabetic foot ulcer: a Mendelian randomization study and mediation analysis.

Niu Z, Mao L, Han L, Niu J, Zhang X, Wei G Arch Dermatol Res. 2025; 317(1):460.

PMID: 39987406 DOI: 10.1007/s00403-025-03942-4.


CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancer.

He X, Liu J, Zhou Y, Zhao S, Chen Z, Xu Z Cell Death Differ. 2025; .

PMID: 39972059 DOI: 10.1038/s41418-025-01464-0.


Causal effects of circulating immune cells on coronary atherosclerosis: Evidence from Mendelian randomization.

Yang X, Yu Y, Hu G, Bai S, Wu J, Guo C Medicine (Baltimore). 2025; 104(5):e41361.

PMID: 39889170 PMC: 11789883. DOI: 10.1097/MD.0000000000041361.


References
1.
Bristeau-Leprince A, Mateo V, Lim A, Magerus-Chatinet A, Solary E, Fischer A . Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells. J Immunol. 2008; 181(1):440-8. DOI: 10.4049/jimmunol.181.1.440. View

2.
Locksley R, Reiner S, Hatam F, Littman D, Killeen N . Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science. 1993; 261(5127):1448-51. DOI: 10.1126/science.8367726. View

3.
Tian D, Yang L, Wang S, Zhu Y, Shi W, Zhang C . Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma. Nat Commun. 2019; 10(1):4246. PMC: 6751182. DOI: 10.1038/s41467-019-12243-0. View

4.
Li H, Adamopoulos I, Moulton V, Stillman I, Herbert Z, Moon J . Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun. 2020; 11(1):2859. PMC: 7275084. DOI: 10.1038/s41467-020-16636-4. View

5.
Alunno A, Bistoni O, Bartoloni E, Caterbi S, Bigerna B, Tabarrini A . IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Ann Rheum Dis. 2012; 72(2):286-92. DOI: 10.1136/annrheumdis-2012-201511. View